Actionable Diversity Plans for Clinical Trial Recruitment and Retention
Diversity action plans—focused on enrolling representative numbers of participants in clinical trials from historically underrepresented racial and ethnic populations—are part of U.S. Food and Drug Administration (FDA) draft guidance published in April 2022....